pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
4452725e-bbac-4542-b958-9ec4ca51a9a3
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-16 18:29:27
Income (reported)
Expenses (reported)
$390,000
Expenses method
A
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

HOLOGIC, INC.

Contact
JULIE KHANI
Phone
+1 202-841-8196
Address
zip:01752, city:Marlborough, state:MA, street:250 Campus Drive

Client

HOLOGIC, INC.

Medical device manufacturer

State
MA
Country
US
Effective date
2022-01-01

Issues lobbied + lobbyists

HCR — Health Issues

Issues related to womens health, including prevention, diagnostics and imaging; issues related to breast and cervical health; global health funding and aid; passage of RESULTS Act (H.R. 5269/S. 2761).

Lobbyists: CAROLINE DOXSEE; PHYLICIA WOODS LISIAK

Government entities lobbied: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS)

TRD — Trade (domestic/foreign)

Issues concerning tariffs affecting medical device equipment.

Lobbyists: CAROLINE DOXSEE; PHYLICIA WOODS LISIAK

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MAN — Manufacturing

Issues related to the right to repair of medical device equipment.

Lobbyists: CAROLINE DOXSEE; PHYLICIA WOODS LISIAK

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

Passage of RESULTS Act (H.R. 5269/S. 2761).

Lobbyists: CAROLINE DOXSEE; PHYLICIA WOODS LISIAK

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.